Ocugen, Inc. (OCGN)
1.385
+0.04
(+3.36%)
USD |
NASDAQ |
May 27, 16:00
1.40
+0.02
(+1.08%)
After-Hours: 16:47
Ocugen Free Cash Flow : -59.58M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| REGENXBIO, Inc. | -236.40M |
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| Sarepta Therapeutics, Inc. | 91.18M |
| Krystal Biotech, Inc. | 237.38M |
| Gilead Sciences, Inc. | 10.23B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.79M |
| Cash from Investing (Quarterly) | -0.006M |
| Cash from Financing (Quarterly) | 34.98M |
| Free Cash Flow Per Share (Quarterly) | -0.0666 |
| Free Cash Flow to Equity (Quarterly) | -21.95M |
| Free Cash Flow to Firm (Quarterly) | -20.48M |
| Free Cash Flow Yield | -13.92% |